The identification of this variant expands the mutational spectrum of ATP8A2‐associated CAMRQ syndrome and underscores the importance of comprehensive genetic testing in diagnosing rare neurological disorders (Heshmatzad et al. 2021; Mahdieh et al. 2024). The gene discussed is ATP8A2; the disease is nervous system disorder.